Log in to save to my catalogue

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-ana...

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-ana...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6222274

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

About this item

Full title

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

Publisher

England: BMJ Publishing Group LTD

Journal title

BMJ (Online), 2018-11, Vol.363, p.k4226

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

To provide a complete toxicity profile, toxicity spectrum, and a safety ranking of immune checkpoint inhibitor (ICI) drugs for treatment of cancer.
Systematic review and network meta-analysis.
Electronic databases (PubMed, Embase, Cochrane Library, and Web of Science) were systematically searched to include relevant studies published in Engli...

Alternative Titles

Full title

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6222274

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6222274

Other Identifiers

ISSN

0959-8138

E-ISSN

1756-1833

DOI

10.1136/bmj.k4226

How to access this item